Cryo-Cell International Profit Margin

Cryo-Cell International posts a profit margin of -7.92% as of May 2026. That compares with -0.54% in the prior-year period — down 1379.6% year over year. That is below the Healthcare sector average of 15.52%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Cryo-Cell International's profit margin was -0.54%. The latest reading is -7.92% — a 1379.6% year-over-year decrease (period ending May 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 15.52% is typical. Cryo-Cell International's -7.92% is lower that level. That is roughly 151.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Cryo-Cell International's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -7.92% as of May 2026; use YoY and peer views to separate noise from signal.

Context for CCEL's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 15.52%), and (3) consistency with growth and profitability. This page covers the first two; Cryo-Cell International's other metric pages and overview cover the third.